Literature DB >> 24384771

Assessment of kidney function in diabetic patients. Is there a role for new biomarkers NGAL, cystatin C and KIM-1?

U Matys, H Bachorzewska-Gajewska, J Malyszko, S Dobrzycki.   

Abstract

PURPOSE: Assessment of kidney injury early detection in diabetic patients has great importance for therapy and prognosis. The aim of this study was to assess whether neutrophil gelatinase-associated lipocalin (NGAL), cystatin C, and kidney injury molecule-1 (KIM-1) could represent sensitive markers of kidney function/injury in patients with coronary heart disease and diabetes.
MATERIALS AND METHODS: The study comprised 121 consecutive patients with diabetes referred for coronary angiography due to coronary heart disease and a reference group consisting of 64 patients without diabetes.
RESULTS: Cystatin C, serum and urinary NGAL values were significantly higher in diabetics than in non-diabetics. There was no significant difference in KIM-1 levels in both groups. Serum NGAL in diabetic group was associated with serum creatinine, fibrinogen, urinary NGAL, cystatin C and inversely related to kidney function assessed with 4 equations. After analysing levels of studied biomarkers in both groups, no significant difference in patients with estimated glomerular filtration rate (eGFR) below 60 ml/min/1.73m² was found. The analysis of patients with eGFR over 60 ml/min/1.73m² showed significant differences in cystatin C and urinary NGAL levels. The area under the curve for serum NGAL, urinary NGAL and cystatin C was 0.60 (95% CI, 0.51 to 0.69), 0.59 (95% CI, 0.5 to 0.68), 0.62 (95% CI, 0.54 to 0.71), respectively, good cut-off values of studied biomarkers to detect diabetes were not found.
CONCLUSION: NGAL, cystatin C and KIM-1 are not more useful than eGFR in the assessment of kidney function in diabetic patients with coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24384771     DOI: 10.2478/v10039-012-0077-8

Source DB:  PubMed          Journal:  Adv Med Sci        ISSN: 1896-1126            Impact factor:   3.287


  5 in total

Review 1.  Novel acute kidney injury biomarkers: their characteristics, utility and concerns.

Authors:  Braian M Beker; Mateo G Corleto; Cecilia Fieiras; Carlos G Musso
Journal:  Int Urol Nephrol       Date:  2018-01-06       Impact factor: 2.370

Review 2.  Novel biomarkers of acute kidney injury: Evaluation and evidence in urologic surgery.

Authors:  Marianne Schmid; Deepansh Dalela; Rana Tahbaz; Jessica Langetepe; Marco Randazzo; Roland Dahlem; Margit Fisch; Quoc-Dien Trinh; Felix K-H Chun
Journal:  World J Nephrol       Date:  2015-05-06

3.  Characterization of renal biomarkers for use in clinical trials: effect of preanalytical processing and qualification using samples from subjects with diabetes.

Authors:  David A Brott; Stephen T Furlong; Scott H Adler; James W Hainer; Ramin B Arani; Mark Pinches; Peter Rossing; Nish Chaturvedi
Journal:  Drug Des Devel Ther       Date:  2015-06-22       Impact factor: 4.162

4.  Serum NGAL and Cystatin C Comparison With Urinary Albumin-to-Creatinine Ratio and Inflammatory Biomarkers as Early Predictors of Renal Dysfunction in Patients With Type 2 Diabetes.

Authors:  Marcelo R Bacci; Ethel Z Chehter; Ligia A Azzalis; Beatriz Costa de Aguiar Alves; Fernando L A Fonseca
Journal:  Kidney Int Rep       Date:  2016-10-15

Review 5.  Evaluation value of neutrophil gelatinase-associated lipocalin for the renal dysfunction of patients with chronic kidney disease: A meta-analysis.

Authors:  Lulu Guo; Yaya Zhao; Zhenzhu Yong; Weihong Zhao
Journal:  Aging Med (Milton)       Date:  2018-09-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.